NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT06462183 2025-11-14Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)Rgenta Therapeutics IncPhase 1 Recruiting105 enrolled
NCT05377996 2025-10-28A Study of XMT-1660 in Participants With Solid TumorsMersana TherapeuticsPhase 1 Recruiting319 enrolled
NCT06805825 2025-09-23A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitNovelty Nobility, Inc.Phase 1 Recruiting67 enrolled
NCT04249947 2025-02-17P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)Poseida Therapeutics, Inc.Phase 1 Terminated40 enrolled
NCT03886831 2023-03-28A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesPrelude TherapeuticsPhase 1 Completed232 enrolled
NCT03291002 2021-11-04Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACCCureVacPhase 1 Unknown98 enrolled
NCT03680560 2020-03-31Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor CancersCogent Biosciences, Inc.Phase 1 Terminated6 enrolled